Research Article: Neutrophil Extracellular Trap is Surrogate Biomarker for Prognosis and Response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer
Introduction:
According to the latest statistics, colorectal cancer is still one of the most prevalent cancers, with the third highest incidence and mortality worldwide, both in men and women. Locally advanced rectal cancer (LARC) is defined as TNM stage II and III, and accounts for ~% of rectal cancer patients. The main treatment of LARC is total mesorectal excision followed by adjuvant chemotherapy. In recent years, neoadjuvant chemoradiotherapy (nCRT) followed by surgery has demonstrated improved survival and outcomes. , By…
Read more